Mach7 Technologies Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
Mach7 Technologies's earnings have been declining at an average annual rate of -3.9%, while the Healthcare Services industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 16.9% per year.
Key information
-3.9%
Earnings growth rate
7.3%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | 16.9% |
| Return on equity | -15.4% |
| Net Margin | -27.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding
Nov 06
Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates
Aug 30Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues
Aug 01Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be
Jan 29Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Nov 23Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?
Sep 29Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)
Sep 04Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching
Jun 13We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow
Apr 28An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued
Oct 24Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?
Jun 23Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?
May 19Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?
Nov 10Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates
Jul 27Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)
Feb 19
The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted
Jan 27Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?
Dec 06Revenue & Expenses Breakdown
How Mach7 Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 29 | -8 | 7 | 0 |
| 31 Mar 24 | 28 | -7 | 7 | 0 |
| 31 Dec 23 | 27 | -6 | 6 | 0 |
| 30 Sep 23 | 29 | -3 | 6 | 0 |
| 30 Jun 23 | 30 | -1 | 7 | 0 |
| 31 Mar 23 | 29 | -2 | 6 | 0 |
| 31 Dec 22 | 28 | -4 | 5 | 0 |
| 30 Sep 22 | 27 | -4 | 5 | 0 |
| 30 Jun 22 | 26 | -4 | 4 | 0 |
| 31 Mar 22 | 26 | -3 | 4 | 0 |
| 31 Dec 21 | 26 | -3 | 3 | 0 |
| 30 Sep 21 | 23 | -6 | 3 | 0 |
| 30 Jun 21 | 19 | -9 | 3 | 0 |
| 31 Mar 21 | 18 | -9 | 3 | 0 |
| 31 Dec 20 | 17 | -8 | 3 | 0 |
| 30 Sep 20 | 18 | -4 | 3 | 0 |
| 30 Jun 20 | 19 | 0 | 3 | 0 |
| 31 Mar 20 | 17 | -1 | 2 | 0 |
| 31 Dec 19 | 15 | -2 | 2 | 0 |
| 30 Sep 19 | 12 | -5 | 2 | 0 |
| 30 Jun 19 | 9 | -7 | 2 | 0 |
| 31 Mar 19 | 9 | -7 | 2 | 0 |
| 31 Dec 18 | 8 | -6 | 2 | 0 |
| 30 Sep 18 | 8 | -5 | 2 | 0 |
| 30 Jun 18 | 9 | -5 | 2 | 0 |
| 31 Mar 18 | 9 | -11 | 3 | 0 |
| 31 Dec 17 | 9 | -17 | 3 | 0 |
| 30 Sep 17 | 10 | -17 | 3 | 0 |
| 30 Jun 17 | 10 | -18 | 4 | 0 |
| 31 Mar 17 | 8 | -16 | 3 | 0 |
| 31 Dec 16 | 6 | -15 | 3 | 0 |
| 30 Sep 16 | 4 | -14 | 3 | 0 |
| 30 Jun 16 | 2 | -13 | 3 | 0 |
| 31 Dec 15 | 8 | -3 | 8 | 0 |
| 30 Jun 15 | 0 | -7 | 2 | 0 |
| 31 Dec 14 | 5 | -3 | 6 | 0 |
| 31 Dec 13 | 3 | -4 | 5 | 0 |
Quality Earnings: M7T is currently unprofitable.
Growing Profit Margin: M7T is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M7T is unprofitable, and losses have increased over the past 5 years at a rate of 3.9% per year.
Accelerating Growth: Unable to compare M7T's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: M7T is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (12.7%).
Return on Equity
High ROE: M7T has a negative Return on Equity (-15.37%), as it is currently unprofitable.